University College London
The method, developed by a University College London-led research team, involves treating sputum samples with acetic acid to inactivate the sample while preserving tuberculosis RNA.
Gates Foundation Awards Multiple Omics, Dx Grants in October, Including $9M for Co-Diagnostics
Awardees include Co-Diagnostics, Quantigen, the African Society for Laboratory Medicine, Broad Institute, and Antibody Solutions.
Personalis MRD Assays to Support UK's TRACERx ctDNA Monitoring Study
The ongoing lung cancer study, which has employed other assays in the past, will now use the Personalis NeXT Personal platform to monitor for recurrence after surgery.
Whole-Genome Sequencing Can Diagnose Neurological Repeat Expansion Disorders, UK Study Finds
The study involved researchers from Queen Mary University of London, University College London, Illumina, and Genomics England and NHS England.
Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration
Saga will use its digital PCR-based SagaSafe assays to analyze hundreds of clinical tissue samples from the TRACERx and PEACE studies.